The company is introducing a limited-time offer at the 2026 AAO annual session to help orthodontic practices implement its light therapy device.
Biolux Technology is introducing a limited-time promotion for OrthoPulse lite at the 2026 American Association of Orthodontists (AAO) annual session in Orlando. The offer is designed to support accelerated adoption, enabling practices to implement the device across their patient base.
Showcasing OrthoPulse Lite at AAO
Attendees can view live demonstrations, clinical insights, and real-world case data for OrthoPulse lite at booth #1268 during the event. The system uses proprietary 850 nm near-infrared light to biologically support tooth movement, a process known as photobiomodulation.
According to Biolux, the streamlined platform integrates across both aligner and fixed appliance workflows, allowing practices to standardize the technology across all patient types.
Clinical Outcomes and Predictability
OrthoPulse is an FDA-cleared device indicated as an adjunct to orthodontic treatment. The company notes that consistent clinical outcomes with the device include accelerated treatment progression, reduced refinements and finishing aligners, and enhanced patient comfort.
“OrthoPulse has fundamentally changed how we deliver care. This isn’t about speed alone—it’s about control and predictability. When you can consistently move teeth as planned, you elevate outcomes across every case. At this point, it’s not optional in our practice—it’s standard of care,” says Dr Paola Leone, L&V Orthodontics, in a release.
Photo: Biolux Technology
